Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Drug law reform when bad policy is good politics
Commentary by Alex Wodak published in the Lancet, “The need for reform of drug laws is now growing in many countries, but change is slow because bad policy is still good politics. Thus, many political systems are unable to move forward with reform of drug laws, and change seems most likely to happen through pressure from civil society.”
Commentary by Alex Wodak published in the Lancet, “The need for reform of drug laws is now growing in many countries, but change is slow because bad policy is still good politics. Thus, many political systems are unable to move forward with reform of drug laws, and change seems most likely to happen through pressure from civil society.”
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication
This study examines hepatic enzyme test results throughout the course of pregnancy in women maintained on methadone or buprenorphine.
This study examines hepatic enzyme test results throughout the course of pregnancy in women maintained on methadone or buprenorphine.
Tackling the problem of hepatitis C, substance misuse and health inequalities: a consensus for London
This document by The London Joint Working Group for Substance Misuse and Hepatitis C, “represents a call to action from experts in the fields of addiction and hepatitis in London. It provides a framework with which to address the epidemiological, clinical and financial challenges presented by current rates of hepatitis C among people who have injected drugs, and sets out solutions in the form of a blueprint for local commissioners”
This document by The London Joint Working Group for Substance Misuse and Hepatitis C, “represents a call to action from experts in the fields of addiction and hepatitis in London. It provides a framework with which to address the epidemiological, clinical and financial challenges presented by current rates of hepatitis C among people who have injected drugs, and sets out solutions in the form of a blueprint for local commissioners”
HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy
This paper provides, “A systematic review to identify and synthesise prevalence estimates and risk factors for HIV among people who inject drugs (PWID) in Central and Eastern Europe and Central Asia.”
This paper provides, “A systematic review to identify and synthesise prevalence estimates and risk factors for HIV among people who inject drugs (PWID) in Central and Eastern Europe and Central Asia.”
IDPC's response to the UNODC World Drug Report 2012
IDPC provides an overview of the data and topics presented in the United Nations Office on Drugs and Crime (UNODC)’s World Drug Report, and where appropriate, within the broader context of the current state of the UN drug control framework, offers a critical analysis of both.
IDPC provides an overview of the data and topics presented in the United Nations Office on Drugs and Crime (UNODC)’s World Drug Report, and where appropriate, within the broader context of the current state of the UN drug control framework, offers a critical analysis of both.
An urgent need to scale-up injecting drug harm reduction services in Tanzania: Prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011
Injecting drug use (IDU) is a growing concern in Tanzania compounded by reports of high risk injecting and sexual risk behaviours among people who inject drugs (PWID).
Injecting drug use (IDU) is a growing concern in Tanzania compounded by reports of high risk injecting and sexual risk behaviours among people who inject drugs (PWID).
South-East Asia Opium Survey 2012 - Lao PDR, Myanmar
Myanmar opium poppy cultivation jumped 17 per cent in 2012 to 51,000 hectares (up from 43,000 ha in 2011) in spite of Government figures showing that 23,717 ha of opium poppy has been eradicated - more than three times the 7,058 ha it eradicated in 2011.
Myanmar opium poppy cultivation jumped 17 per cent in 2012 to 51,000 hectares (up from 43,000 ha in 2011) in spite of Government figures showing that 23,717 ha of opium poppy has been eradicated - more than three times the 7,058 ha it eradicated in 2011.
HIV outbreak among injecting drug users in Greece
This is an updated report for the EMCDDA on the recent outbreak of HIV infections among drug injectors in Greece
This is an updated report for the EMCDDA on the recent outbreak of HIV infections among drug injectors in Greece
Pregnancy, childcare and the family: key issues for Europe’s response to drugs 2012
EMCDDA‘s overview on the extent of, and available responses to, the problems of pregnant drug users and families that are affected by drug use. In the first part of the report, a description of the available data on the extent of drug use during pregnancy and associated risks is followed by a review of responses to drug use among pregnant women across Europe. The second part of the publication focuses on children living in the care of drug users.
EMCDDA‘s overview on the extent of, and available responses to, the problems of pregnant drug users and families that are affected by drug use. In the first part of the report, a description of the available data on the extent of drug use during pregnancy and associated risks is followed by a review of responses to drug use among pregnant women across Europe. The second part of the publication focuses on children living in the care of drug users.
US Office of National Drug Control Policy releases briefing on medication-assisted treatment
The US Office of National Drug Control Policy (ONDCP) has released a new briefing on options for the treatment of opioid dependence including guidance on the use of methadone and buprenorphine.
The US Office of National Drug Control Policy (ONDCP) has released a new briefing on options for the treatment of opioid dependence including guidance on the use of methadone and buprenorphine.
